PARTNERSHIP OPPORTUNITIES
Attention
Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Please register your interest here if you would like updates on the meeting or topic.
Partnership Opportunities
The Novel Combination Cancer Immunotherapy Summit 2024 was the first and only industry dedicated forum bringing together biopharma and solution providers under one roof to solely focus on forging partnerships and collaborations that accelerate translation and clinical development of rational, safe and durable combination therapies that effectively address unmet clinical needs for cancer patients.
If you have expertise in preclinical, translational and clinical development, partner with us to support drug developers in their quest to bring effective combination cancer immunotherapies towards approval.
Why Partner?
This is your opportunity to showcase your valuable expertise and excellent customer service, establishing yourself as a front runner in the immuno-oncology space.
Face to face connections with the key players in immuno-oncology, including big pharma and pioneering biotech companies.
Position yourself as a top-tier industry expert in the evolving immuno-oncology space.
Gain valuable market intelligence and tailor your services in response to the emerging needs of immuno-oncology experts.
Maximise your brand visibility and develop commercial collaborations through pre- and post-conference exposure to key opinion leaders.
Share your message with a targeted audience of immuno-oncology decision makers, elevating yourself from competitors.
Who Would You Have Met?
Raise Brand Awareness
& Generate Commercial
Collaborations
Generate commercial
opportunities with 6+ hours of
built-in networking time with
C-Levels, VPs and Directors of
immuno-oncology, preclinical
and clinical researches to deliver
on your 2024/2025 business
objectives
Meet & Network with Industry
Pioneers
Promote your brand to
powerhouses and newcomers in
the field of immuno-oncology and
forge meaningful connections
Benefit from Market
Intelligence
Expand your networking horizons
by meeting key biopharma
decision makers across 3-days
of networking, data sharing, and
case study analysis to match your
solutions to the market